tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 963 are a BUY (93.5%), 64 are a HOLD (6.21%), 3 are a SELL (0.29%).
Analyst Raghuram Selvaraju, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 35.94% that have a potential upside of 56.66% achieved within 198 days.
Raghuram Selvaraju’s has documented 1,899 price targets and ratings displayed on 125 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on GMAB, Genmab AS at 01-Oct-2025.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for EVOK (EVOKE PHARMA) at 7/18/2016. The price target of $288 was fulfilled within 3 days with a profit of $128.16 (30.8%) receiving and performance score of 102.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$12
$-6.84 (-36.31%)
$7
3 months 10 days ago
(24-Jun-2025)
8/13 (61.54%)
$-4.19 (-25.88%)
55
Buy
1 years 3 months 17 days ago
(17-Jun-2024)
10/37 (27.03%)
$101 (102.02%)
298
Sell
1 years 10 months 15 days ago
(19-Nov-2023)
1/3 (33.33%)
$-0.8 (-0.99%)
300
Hold
$20
$1.16 (6.16%)
$60
1 years 11 months 10 days ago
(24-Oct-2023)
3/22 (13.64%)
$5.72 (40.06%)
40
Hold
$25
$6.16 (32.70%)
$40
2 years 2 months 16 days ago
(18-Jul-2023)
2/5 (40%)
$3.4 (15.74%)
215
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
